1887
Volume 2014, Issue 1
  • ISSN: 2305-7823
  • E-ISSN:

Abstract

The use of bivalirudin during primary percutaneous coronary intervention (PPCI) is perceived to be associated with less bleeding compared to unfractionated heparin (UFH). However, evidence supporting this observation is confounded by the frequent co-administration of glycoprotein IIb/IIIa inhibitors in the UFH arm in the majority of previous large trials. The “How Effective Are Antithrombotic Therapies in Primary PCI (HEAT-PPCI)” trial was conducted to test the efficacy and safety of UFH vesrus bivalirudin in patients undergoing PPCI when GP IIb/IIIa inhibitors are used selectively.

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2014.7
2014-07-01
2019-11-20
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2014/1/gcsp.2014.7.html?itemId=/content/journals/10.5339/gcsp.2014.7&mimeType=html&fmt=ahah

References

  1. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) , Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, DiMario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van't Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012 Oct; 33:20:25692619, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22922416 .
    [Google Scholar]
  2. American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions , O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013 Jan 29; 61:4:e78e140, Available from: http://www.ncbi.nlm.nih.gov/pubmed/23256914 .
    [Google Scholar]
  3. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R, HORIZONS-AMI Trial Investigators . Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008 May 22; 358:21:22182230, Available from: http://www.ncbi.nlm.nih.gov/pubmed/18499566 .
    [Google Scholar]
  4. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Fahy M, Parise H, Mehran R, HORIZONS-AMI Trial Investigators . Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet. 2011 Jun 25; 377:9784:21932204, Available from: http://www.ncbi.nlm.nih.gov/pubmed/21665265 .
    [Google Scholar]
  5. Steg PG, van't Hof A, Hamm CW, Clemmensen P, Lapostolle F, Coste P, Ten Berg J, Van Grunsven P, Eggink GJ, Nibbe L, Zeymer U, Campo dell' Orto M, Nef H, Steinmetz J, Soulat L, Huber K, Deliargyris EN, Bernstein D, Schuette D, Prats J, Clayton T, Pocock S, Hamon M, Goldstein P, EUROMAX Investigators . Bivalirudin started during emergency transport for primary PCI. N Engl J Med. 2013 Dec 5; 369:23:22072217, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24171490 .
    [Google Scholar]
  6. Lincoff AM, Kleiman NS, Kereiakes DJ, Feit F, Bittl JA, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ, REPLACE-2 Investigators . Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003 Feb 19; 289:7:853863, Available from: http://www.ncbi.nlm.nih.gov/pubmed/12588269 .
    [Google Scholar]
  7. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, Ebrahimi R, Hamon M, Rasmussen LH, Rupprecht HJ, Hoekstra J, Mehran R, Ohman EM, ACUITY Investigators . Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006 Nov 23; 355:21:22032216, Available from: http://www.ncbi.nlm.nih.gov/pubmed/17124018 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2014.7
Loading
  • Article Type: Research Article
Keyword(s): bivalirudin , HEAT-PPCI , primary PCI , STEMI and unfractionated heparin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error